Work

Depth of response and progression-free survival in chronic lymphocytic leukemia patients treated with ibrutinib

Year: 2022

Type: article

Source: Leukemia

DOI: 10.1038/s41375-022-01640-y

Authors: Audrey M. Sigmund, Ying Huang, Amy S. Ruppert, Kami Maddocks, Kerry A. Rogers, Samantha Jaglowski, Seema A. Bhat, Adam S. Kittai, Michael R. Grever, John C. Byrd, Jennifer A. Woyach

Institutions: The Ohio State University, University of Cincinnati, The Ohio State University Wexner Medical Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: Targeted Therapy for Leukemia, Targeted Therapies for Lymphoid Malignancies

OpenAlex ID: W4285588445

FWCI: 0.466

Cites: 14

Cited by: 3

Related to: 10